Consistent with the scRNA-seq data of 8-day treated T22 tumors, a slight decrease of MHC-IIloC5aR1hi pro-tumor macrophages after olaparib treatment was only observed in non-transferred models but not in C5aR1hi cell transferred models. This evidence concerns the gene HLA-C and neoplasm.